Skip to main content
logo
Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
17.86
-0.43 (-2.32%)
At close: Jul 24, 2026, 4:00 PM EDT
17.75
-0.11 (-0.59%)
After-hours: Jul 24, 2026, 7:22 PM EDT

Quince Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-48.05-83.98-56.83-31.39-51.66-89.95
Depreciation & Amortization
0.180.140.190.320.20.34
Stock-Based Compensation
6.395.114.755.2216.6229.85
Other Adjustments
-14.5424.4620.485.570.631.08
Changes in Accounts Payable
4.95-0.940.93-0.29-5.941.36
Changes in Accrued Expenses
-2.295.781.07-1.97-6.66-4.63
Changes in Other Operating Activities
5.258.01-2.484.242.77-0.98
Operating Cash Flow
-39.45-41.43-31.9-18.29-44.04-62.93
Capital Expenditures
-0.35-0.35-0.26-0.16-0.13-0.18
Sale of Property, Plant & Equipment
---0.090.07-
Purchases of Investments
-32.46-34.42-89.56-113.78-75.02-38.79
Proceeds from Sale of Investments
69.9858111.73111.2182.4997.92
Payments for Business Acquisitions
----2.12--
Other Investing Activities
----110.59-
Investing Cash Flow
35.2223.2321.91-5.761858.95
Long-Term Debt Repaid
-5.55-----
Net Long-Term Debt Issued (Repaid)
-5.55-----
Issuance of Common Stock
15.1217.910.230.150.766.81
Net Common Stock Issued (Repurchased)
15.1217.910.230.150.766.81
Other Financing Activities
---5-0.01-0.05-
Financing Cash Flow
27.2717.91-4.780.140.716.81
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-1.75-0.110.230.080.180.06
Net Cash Flow
10.39-0.4-14.54-23.83-25.152.88
Free Cash Flow
-39.8-41.78-32.16-18.45-44.17-63.11
Free Cash Flow Per Share
-128.28-166.78-148.68-99.11-263.74-424.73
Levered Free Cash Flow
-30.84-71.35-57.38-29.25-61.42-94.04
Unlevered Free Cash Flow
-46.5-47.75-57.93-32.27-61.49-94.42
SEC Filings: 10-K · 10-Q